Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

AMGLIDIA 0.6 mg/mL, oral suspension with 1 mL oral syringe

Active Ingredient:
glibenclamide
Company:  
Bioprojet UK Limited See contact details
ATC code: 
A10BB01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 07 Sep 2022
{pdf} View or print the patient leaflet as PDF
Bioprojet UK Limited
Company image
Address
Unit B Stanley Court, Glenmore Business Park, Telford Road, Salisbury, Wiltshire, SP2 7GH, UK
WWW
www.bioprojet.uk
Telephone
+44 (0) 1722 742 900
E-mail
[email protected]
Medical Information Direct Line
+44 (0)1271 334 609
Customer Care direct line
+44 (0)1722 742 900